ABX-CRO Advanced Pharmaceutical Services GmbH FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Jan 23, 2026
  • No warning letters matched by name
Inspections 2 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

ABX-CRO Advanced Pharmaceutical Services GmbH has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "ABX-CRO Advanced Pharmaceutical Services GmbH" is on file.

What these totals cover: FDA records filed under the name "ABX-CRO Advanced Pharmaceutical Services GmbH" and its spelling variant "Abx-Cro Advanced Pharmaceutical Services".

Latest inspection
Jan 23, 2026 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections2Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

ABX-CRO Advanced Pharmaceutical Services GmbH's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

ABX-CRO Advanced Pharmaceutical Services GmbH: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202510000
202400000
202300000
202200000
202100000
202000000
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing ABX-CRO Advanced Pharmaceutical Services GmbH as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check ABX-CRO Advanced Pharmaceutical Services GmbH yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent FDA inspections

2 inspections from Apr 30, 2025 to Jan 23, 2026.

DateSiteProductClassificationFEI
Jan 23, 2026Dresden, GermanyDrugsNo Action Indicated (NAI)3014293429
Apr 30, 2025Dresden, GermanyDrugsNo Action Indicated (NAI)3014293429
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3014293429Dresden, Germany2Jan 23, 2026

ABX-CRO Advanced Pharmaceutical Services GmbH and the FDA: common questions

Has ABX-CRO Advanced Pharmaceutical Services GmbH received an FDA warning letter?

No FDA warning letter addressed to the name "ABX-CRO Advanced Pharmaceutical Services GmbH" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has ABX-CRO Advanced Pharmaceutical Services GmbH received an FDA Form 483?

FDA has not published a Form 483 for "ABX-CRO Advanced Pharmaceutical Services GmbH" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect ABX-CRO Advanced Pharmaceutical Services GmbH?

The most recent FDA inspection on file ended Jan 23, 2026 at Dresden, Germany and was classified NAI. FDA has 2 inspections of ABX-CRO Advanced Pharmaceutical Services GmbH on file.

Need more than this page shows? Ask about ABX-CRO Advanced Pharmaceutical Services GmbH in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.